Skip to main content

JHOP - Sept 2016 Vol 6, No 3

The Importance of Monitoring Cardiotoxicity in Patients with Breast Cancer

Sandra Cuellar Puri, PharmD, BCOP

Original Research

The Effect of Written Pharmacist-Provided Patient Education for 3 Frequently Prescribed Oral Anticancer Agents on the Incidence of Patient-Initiated Triage Calls

Nicolas De Padova, PharmD, Robert Grabowski, PharmD, Joseph Ineck, PharmD, CPE, Robert Mancini, PharmD, BCOP, FHOPA

Supportive Care

HER2 Receptor Antagonist–Associated Cardiotoxicity

Alison Palumbo, PharmD, MPH, BCOP, Joseph Bubalo, PharmD, BCPS, BCOP

Overview of the Current Treatment Paradigm in Chronic Lymphocytic Leukemia, Part 2

Austin J. Combest, PharmD, BCOP, MBA, Ryan C. Danford, PharmD, Elizabeth R. Andrews, PharmD, Ashley Simmons, PharmD, Paulina McAtee, PharmD, Dirk J. Reitsma, MD

Lung Cancer

Adjusted Dosing and Schedule of Pemetrexed in Impaired Renal Function

Zahava Ohana, PharmD, Amanda Brahim, PharmD, BCPS, Mohammed Ibrahim, RPh, BCOP, BCPS, BCACP

From the Literature

Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy

Results 1 - 6 of 6